XBIO Xenetic Biosciences, Inc. Stock DD Monday, March 31, 2014

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
XBIO Xenetic Biosciences, Inc. $XBIO Company Overview 

Stock Message Board http://investorshangout.com/search?q=XBIO&...mp;yt1=Go!

Last Updated: Monday, March 31, 2014 02:14:02 AM

Xenetic Biosciences, Inc. XBIO Current Price and Quotes
Last Price 0.95
Previous Close 1.00 Open 0.75
Daily Range 1.00 - 0.75 52wk Range 10.00 - 0.70
Volume 6,597 Dividend N/A
Average Vol (3m) 10,478 Yield N/A
Xenetic Biosciences, Inc. XBIO
Company Information

99 Hayden Avenue
Suite 230
Lexington, MA 02421

Phone: 781-778-7722

Xenetic Biosciences, Inc. XBIO
Not Available

Xenetic Biosciences, Inc. XBIO
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Nov 30, 2013 10-Q
CIK 0001534525
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 4522 - Air transportation, nonscheduled
Business Status Development Stage Company a/o Mar 02, 2012
Incorporated In: NV, USA
Year of Inc. 2011
Employees 1 a/o Mar 02, 2012
Company Officers/Contacts

M Scott Maguire CEO
Colin William Hill CFO
Company Directors

Firdaus Jal Dastoor
Colin William Hill
Artur Isaev
M Scott Maguire
Brian Richards
Company Notes

Formerly=General Sales & Leasing, Inc. until 1-2014
Formerly=General Aircraft Inc. until 2-2013
Service Providers

Auditor/Accountant
Weaver Martin & Samyn
411 Valentine Road
Suite 300
Kansas City, MO, 64111
United States

Legal Counsel
Not Available
Investor Relations Firm
Not Available

Xenetic Biosciences, Inc. XBIO
XBIO Security Details

Share Structure

Market Value1 $129,243,229 a/o Mar 28, 2014
Shares Outstanding 136,045,504 a/o Jan 23, 2014
Float Not Available
Authorized Shares Not Available
Par Value  0.01
Shareholders

Shareholders of Record Not Available
Security Notes

Capital Change=shs increased by 10 for 1 split Ex-date=03/01/2013. Rec date=02/25/2013. Pay date=02/28/2013.
Capital Change=shs decreased by 1 for 10 split. Ex-date=01/14/2014.
Short Selling Data

Short Interest 0 (-100%)
Mar 14, 2014
Significant Failures to Deliver  No
Transfer Agent(s)

Empire Stock Transfer Inc.

Xenetic Biosciences, Inc. XBIO Financials
Period Ending Aug 31, 2013 Aug 31, 2012
Total Revenue 97 113
Cost of Revenue - -
Gross Profit 97 113
Operating Expenses

Research and Development - -
Sales, General and Admin. 124 210
Non-Recurring Items - -
Other 39 19
Operating Income (66) (117)
Income From Continuing Operations

Add'l Income/Expense Items (11) -
Earnings Before Interest and Tax (76) (117)
Interest Expense 13 13
Earnings Before Tax (89) (130)
Income Tax - -
Minority Interest - -
Equity Earnings Unconsolidated Subsidiary - -
Net Income Cont. Operations (89) (130)
Non Recurring Events

Discontinued Operations - -
Extraordinary Items - -
Effect of Accounting Changes - -
Other Items - -
Net Income (89) (130)
Preferred Stock and Other Adjustments - -
Net Income Applicable to Common Shareholders (89) (130)

Xenetic Biosciences, Inc. XBIO Recent News

Mar 4, 2014 Xenetic Biosciences Announces Opening of Corporate Headquarters and R&D Facility in Lexington, MA
Feb 14, 2014 Xenetic Biosciences Announces Ticker Symbol Change to XBIO
Feb 10, 2014 Xenetic Biosciences Appoints Timothy Cote, MD, MPH, Former Head of FDA Orphan Drug Division, to Board of Directors
Jan 30, 2014 Baxter Announces Restructured Agreement with Xenetic Biosciences, Further Bolstering Its Broad Bleeding Disorder Pipeline
Jan 30, 2014 Xenetic Biosciences Announces Restructured Licensing Agreement With Baxter Now Totaling Up to $100 Million, in Addition to $10 Million Equity Investment
Jan 9, 2014 Cirrus Aircraft 2013 Delivered 275 SR Planes


XBIO Xenetic Biosciences, Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=XBIO&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/XBIO/quote
Stock Chart http://www.otcmarkets.com/stock/XBIO/chart
Company Info http://www.otcmarkets.com/stock/XBIO/company-info
Recent News http://www.otcmarkets.com/stock/XBIO/news
Financials http://www.otcmarkets.com/stock/XBIO/financials
Filings and Disclosure http://www.otcmarkets.com/stock/XBIO/filings
Short Sales http://www.otcmarkets.com/stock/XBIO/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/XBIO/insider-transactions
Research Reports http://www.otcmarkets.com/stock/XBIO/research
Summary http://finance.yahoo.com/q?s=XBIO
Historical Prices http://finance.yahoo.com/q/hp?s=XBIO+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=XBIO
Basic Chart http://finance.yahoo.com/q/bc?s=XBIO+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=XBIO+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=XBIO+Headlines
Press Releases http://finance.yahoo.com/q/p?s=XBIO+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=XBIO+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=XBIO+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=XBIO+Industry
Major Holders http://finance.yahoo.com/q/mh?s=XBIO+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=XBIO+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=XBIO+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=XBIO
Balance Sheet http://finance.yahoo.com/q/bs?s=XBIO
Cash Flow http://finance.yahoo.com/q/cf?s=XBIO+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/XBIO
Market Watch http://www.marketwatch.com/investing/stock/XBIO
Bloomberg http://www.bloomberg.com/quote/XBIO:US
Morningstar http://quotes.morningstar.com/stock/s?t=XBIO
Bussinessweek http://investing.businessweek.com/research/st...icker=XBIO
Barchart http://www.barchart.com/quotes/stocks/XBIO
OTC Short Report http://otcshortreport.com/index.php?index=XBIO
Investopedia http://www.investopedia.com/markets/stocks/XBIO/?wa=0
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Truss Financial Tackles Home Equity Closing Delays

Updated Category News Views 23

Truss Financial Group's Bold Move Against Closing Delays In real estate, time is money. Even the most casual market observer could tell you delays can slice through a deal like a hot knife through butter. That's the headache home equity borrowers face, blindsided by closing delays that sneak up on them without warning. An Industry Bottleneck Finally Addressed Enter Truss...

Continue Reading
ROKFORM’s Signal Card: A Wallet Tracker for All

Updated Category News Views 11

The Gadget You Didn't Know You Needed Ever feel that momentary panic when your wallet seems to have vanished into thin air? ROKFORM's fresh offering, the Signal Card, tackles that heart-stopping moment head-on. They've taken the mundane act of misplacing your wallet and transformed it with their sleek, credit-card-sized tracker. This baby pairs seamlessly with Apple Find...

Continue Reading
Charter Next Generation Unveils Gen 2 MDO-PE Films

Updated Category News Views 14

Peering Into CNG's Latest Innovation Charter Next Generation (CNG) just threw down a hefty gauntlet with its launch of next-gen machine-direction-oriented polyethylene (MDO-PE) solutions. They're pushing the envelope on what recycle-ready packaging can do, folks. Let's not mince words—other players in the field better have their game faces on. This ain't just another...

Continue Reading
Cala Launches Game-Changer Wearable for Tremor Relief

Updated Category News Views 13

Breaking New Ground in Neuromodulation Medical tech's on a roll, and Cala Health just hopped on the fast track with their latest launch—the Cala kIQ Plus System. This bad boy is aiming to offer relief for those grappling with hand tremors, thanks to its FDA clearance and a host of new features. It's the first of its kind, combining multiple therapy modes with an...

Continue Reading
Community Banks Missing $106B Lending Opportunity?

Updated Category News Views 28

A Missed Opportunity for Community Banks It's a classic tale: community banks sleepwalking while big players snatch up low-hanging fruit right in their own backyards. According to the latest report by Cornerstone Advisors, commissioned by Teslar Software, these banks are essentially leaving $106 billion on the table when it comes to consumer lending. That's not just chump...

Continue Reading
NYSE Texas Redefines the U.S. Capital Markets Landscape

Updated Category News Views 21

NYSE Texas: Carving a Niche The notion of 'Y'all Street' might seem like a gimmick, but NYSE Texas is pushing a serious agenda with its newly released white paper, 'NYSE Texas and the Reshaping of U.S. Capital Markets.' This is no small feat. Texas is already housing 235 NYSE-listed companies, boasting a colossal combined worth of $4.8 trillion. With 130 of these firms...

Continue Reading
Dentistry.One Achieves HITRUST i1, Boosts Cybertrust

Updated Category News Views 21

HITRUST i1 Certification: The Gold Standard in Security For a world increasingly reliant on digital infrastructure, cybersecurity certification is no longer just a badge of honor; it's a cornerstone of trust. Dentistry.One nailed this down by bagging that coveted HITRUST i1 certification. When folks talk about securing data, HITRUST might as well be speaking gospel. We're...

Continue Reading
Purina Institute Highlights Nutritional Science at WSAVA 2026

Updated Category News Views 19

A Global Stage for Pet Nutrition Science The folks over at the Purina Institute are back in the spotlight as they gear up to throw their weight behind the 51st World Small Animal Veterinary Association (WSAVA) Congress in Warsaw, Poland. Set for October 13-15, 2026, this isn’t just another event—they're bringing some serious clout with their 'Food for Thought'...

Continue Reading
IWP and VYRE Unveil 'The Plug' for VBNGtv Content

Updated Category News Views 20

Bringing Capital and Content Under One Roof There's something in the air as Itibari-Waynne & Partners (IWP) team up with the VYRE Network to crank out a fresh slate of content for VYRE Business News Global (VBNGtv). This partnership ain't just another splash in the buzzy world of digital media; it's like merging Wall Street with Hollywood. IWP, prepping to go full...

Continue Reading
Northern Jet Names Veteran Matthew Harris as CEO

Updated Category News Views 33

Fresh Leadership at Northern Jet Well, if you didn’t see this coming, you’ve been snoozing on the tarmac. Northern Jet, no stranger to the skies after three decades, just roped in Matthew Harris as their new CEO from October 2, 2026. They're pulling in this hotshot with more than 25 years riding the turbulence of private aviation. And listen to this: his marching...

Continue Reading

Top 5 Most Recently Viewed Articles

Exciting Groundbreaking for New Community by Century Communities

Updated Category News Views 191

Century Communities Breaks Ground on New Development Century Communities, Inc. (NYSE: CCS) has recently made headlines with the groundbreaking of its newest venture: a magnificent 318-acre community named Mirabella. This family-friendly location promises to provide over 1,000 new homes designed for affordability and comfort. Situated within the bustling west metro area of...

Continue Reading
Perseus Group Enhances Manufacturing Software with OptiVision

Updated Category News Views 105

Perseus Group Strengthens Its Position in the Industry Perseus Group, a dynamic operating group within Constellation Software Inc., has taken a significant step in enhancing its offerings in the pulp and paper sector. They recently announced the completion of an exciting acquisition that will support their growth strategy. The group has secured the exclusive global...

Continue Reading
Embrace Pet Insurance Breaks Records in Volunteerism and Giving

Updated Category News Views 267

Embrace Pet Insurance Partners in Charity and Volunteerism Despite facing economic hurdles, charitable contributions across the nation showed remarkable resilience, highlighting the generosity of individuals and businesses alike. Recent reports reveal that charitable donations in the U.S. hit staggering heights, exceeding $557 billion in the last reporting year. Embrace...

Continue Reading
Biocon Biologics Achieves Key FDA Approval for Jobevne™ in Oncology

Updated Category News Views 173

Biocon Biologics Secures FDA Approval for Jobevne™ Biocon Biologics Ltd, a subsidiary of Biocon Ltd, has achieved a significant milestone with the U.S. Food and Drug Administration (FDA) granting approval for Jobevne™ (bevacizumab-nwgd). This biosimilar to the well-known Avastin (bevacizumab) is designed for intravenous use and aims to treat various types of cancer....

Continue Reading